Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

Residual Complexes Containing SMARCA2 (BRM) Underlie the Oncogenic Drive of SMARCA4 (BRG1) Mutation

(2014) B. G. Wilson et al.   MOLECULAR AND CELLULAR BIOLOGY

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

(2014) G. R. Hoffman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1

(2013) T. Oike et al.   CANCER RESEARCH

Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics

(2013) Lisa F Gamwell et al.   Orphanet Journal of Rare Diseases

Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study

(2013) Jolanta Kupryjańczyk et al.   POLISH JOURNAL OF PATHOLOGY

Small cell carcinoma of the ovary of hypercalcemic type: a case report

(2012) J. Matt McDonald et al.   JOURNAL OF PEDIATRIC SURGERY

The BRG1 Chromatin Remodeler Protects Against Ovarian Cysts, Uterine Tumors, and Mammary Tumors in a Lineage-Specific Manner

(2012) Daniel W. Serber et al.   PLoS One

Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases published in the literature

(2011) Rebecca Estel et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature

(2010) Raj Kumar Shrimali et al.   MEDICAL ONCOLOGY

Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors

(2010) Katherine W. Eaton et al.   PEDIATRIC BLOOD & CANCER

Familial small cell carcinoma of the ovary

(2009) Anibal R. Martinez-Borges et al.   PEDIATRIC BLOOD & CANCER